OIAM
LEGN icon

OFI Invest Asset Management’s Legend Biotech LEGN Stock Holding History

OFI Invest Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31K Hold
1,228
– – ﹤0.01% 363
2026
Q1 		$19.3K Hold
1,228
– – ﹤0.01% 346
2025
Q4 		$22.7K Hold
1,228
– – ﹤0.01% 368
2025
Q3 		$34.1K Buy
1,228
+622
+103% +$23K ﹤0.01% 296
2025
Q2 		$18.3K Sell
606
-1,106
-65% -$35.8K ﹤0.01% 310
2025
Q1 		$53.8K Sell
1,712
-723
-30% -$25.9K ﹤0.01% 345
2024
Q4 		$76.5K Buy
+2,435
New +$101K ﹤0.01% 275

Other funds holding LEGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $177M AUM 10.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

OFI Invest Asset Management's LEGN Position: Q2 2026 in Review

OFI Invest Asset Management held its Legend Biotech (LEGN) position steady in Q2 2026 at 1,228 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

OFI Invest Asset Management first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $76.5K in Q4 2024. 81 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • OFI Invest Asset Management held 1,228 shares of Legend Biotech worth $31K as of Q2 2026.
  • OFI Invest Asset Management left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of OFI Invest Asset Management's portfolio in Q2 2026, its #363 holding.
  • OFI Invest Asset Management first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
  • OFI Invest Asset Management's Legend Biotech position peaked at $76.5K in Q4 2024.
  • 81 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.